Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Asset Writedowns and Impairment (2017 - 2024)

Historic Asset Writedowns and Impairment for Perspective Therapeutics (CATX) over the last 3 years, with Q3 2024 value amounting to -$14000.0.

  • Perspective Therapeutics' Asset Writedowns and Impairment changed N/A to -$14000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $312000.0, marking a year-over-year change of. This contributed to the annual value of $624000.0 for FY2023, which is N/A changed from last year.
  • Perspective Therapeutics' Asset Writedowns and Impairment amounted to -$14000.0 in Q3 2024.
  • Over the past 5 years, Perspective Therapeutics' Asset Writedowns and Impairment peaked at $326000.0 during Q4 2023, and registered a low of -$14000.0 during Q3 2024.